Peripheral Vascular & Interventional Cardiology Devices Market (2011 – 2016) - Global Trends & Competitive Analysis
Peripheral Vascular & Interventional Cardiology Devices Market (2011 – 2016) (balloons, Evar Stent Grafts, IVC Filter, IVUS & Angiography Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Accessory Devices) Global Trends & Competitive Analysis
The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration devices and accessory devices. This Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016. Moreover, the global stents market for coronary and peripheral procedures was valued at $16.0 billion in 2011 and is expected to grow at a CAGR of 9.5% to reach $25.2 billion by 2016.
A significant growth has been seen in the use of interventional endovascular procedures in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. The coronary and peripheral vascular markets together contribute to this growth in interventional procedures. The peripheral angioplasty procedures are expected to grow at a faster rate with a CAGR of 8.9% and is expected to reach 3.3 million procedures by 2016, while coronary angioplasty procedures will have a steady growth with a CAGR of 6.7% and estimated to reach 4.5 million procedures by 2016.
The major driving factor for these markets would be the increasing demand for minimally invasive percutaneous endovascular treatment. As the incidence cases of coronary and peripheral artery diseases continue to rise in the coming years along with increasing trends in co-morbid conditions such as obesity and diabetes, the vascular interventional devices market for treating these diseases would show significant growth in the forecast period. Minimally invasive endovascular procedure refers to the surgery performed with minute incisions in the body to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such lower extremities, neck, kidneys and brain. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, bleeding, and shorter hospital stays.
The stents used in interventional procedures represent the largest segment of the market. In the global stents market, drug-eluting stents contributed the largest share with 76% of the total market, generating revenue of $8.9 billion in 2011 and is expected to reach $13.7 billion by 2016. The key driving factor for drug-eluting stents would be the increased usage of these stents, as restenosis complications are considerably reduced by these stents compared to bare metal stents as well as DES show less long-term problems after placement.
North America will be the biggest market for vascular interventional devices, followed by Europe. However, Asian countries represent the fastest growing markets as low procedural and infrastructural costs have led to an increased drive of patients from developed regions towards Asian countries such as India and China. Moreover, established players in the market such as Abbott Vascular (U.S.), Boston Scientific (U.S.) and Medtronic Inc. (U.S.) have shown an increased inclination towards Asian countries for market expansion.
Major players in the market include Abbott Vascular, Boston Scientific, Medtronic Inc., C.R. Bard Inc. (U.S.), B Braun Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.), St. Jude Medical (U.S.), Teleflex Medical (U.S.), Terumo Interventional Systems Inc. (Japan), Bayer, Edward Lifesciences, Covidien (Ireland), Endologix (U.S.), W.L.Gore & Associates Ltd. (U.S.), Volcano Corporation (U.S.), Angioscore Ltd. (U.S.) among others.
The global vascular interventional devices market consist of devices used in both coronary and peripheral endovascular procedures which includes balloons, EVAR stent grafts, IVC filters, IVUS & angiography catheters, plaque modification devices, hemodynamic flow alteration devices and accessory devices. This Interventional Cardiology Devices Market was valued at $8.7 billion in 2011 and is poised to grow at a CAGR of 7.8% to reach $12.7 billion by 2016. Moreover, the global stents market for coronary and peripheral procedures was valued at $16.0 billion in 2011 and is expected to grow at a CAGR of 9.5% to reach $25.2 billion by 2016.
A significant growth has been seen in the use of interventional endovascular procedures in the recent years, which is largely driven by healthcare, demographic, and cost-effective factors. The coronary and peripheral vascular markets together contribute to this growth in interventional procedures. The peripheral angioplasty procedures are expected to grow at a faster rate with a CAGR of 8.9% and is expected to reach 3.3 million procedures by 2016, while coronary angioplasty procedures will have a steady growth with a CAGR of 6.7% and estimated to reach 4.5 million procedures by 2016.
The major driving factor for these markets would be the increasing demand for minimally invasive percutaneous endovascular treatment. As the incidence cases of coronary and peripheral artery diseases continue to rise in the coming years along with increasing trends in co-morbid conditions such as obesity and diabetes, the vascular interventional devices market for treating these diseases would show significant growth in the forecast period. Minimally invasive endovascular procedure refers to the surgery performed with minute incisions in the body to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such lower extremities, neck, kidneys and brain. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, bleeding, and shorter hospital stays.
The stents used in interventional procedures represent the largest segment of the market. In the global stents market, drug-eluting stents contributed the largest share with 76% of the total market, generating revenue of $8.9 billion in 2011 and is expected to reach $13.7 billion by 2016. The key driving factor for drug-eluting stents would be the increased usage of these stents, as restenosis complications are considerably reduced by these stents compared to bare metal stents as well as DES show less long-term problems after placement.
North America will be the biggest market for vascular interventional devices, followed by Europe. However, Asian countries represent the fastest growing markets as low procedural and infrastructural costs have led to an increased drive of patients from developed regions towards Asian countries such as India and China. Moreover, established players in the market such as Abbott Vascular (U.S.), Boston Scientific (U.S.) and Medtronic Inc. (U.S.) have shown an increased inclination towards Asian countries for market expansion.
Major players in the market include Abbott Vascular, Boston Scientific, Medtronic Inc., C.R. Bard Inc. (U.S.), B Braun Inc. (Germany), Cook Medical (U.S.), Cordis Corp. (U.S.), St. Jude Medical (U.S.), Teleflex Medical (U.S.), Terumo Interventional Systems Inc. (Japan), Bayer, Edward Lifesciences, Covidien (Ireland), Endologix (U.S.), W.L.Gore & Associates Ltd. (U.S.), Volcano Corporation (U.S.), Angioscore Ltd. (U.S.) among others.
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Increasing Demand for Minimally Invasive Treatment
3.2.1.2 Increasing Incidence of Coronary Artery Disease
3.2.1.3 Increasing Prevalence of Peripheral Vascular Disease
3.2.1.4 Rapid Advancements in New Technologies
3.2.2 RESTRAINTS
3.2.2.1 Reimbursement Issues
3.2.2.2 Declining Average Selling Prices
3.2.2.3 Barrier to Entry
3.2.3 OPPORTUNITIES AND THREATS
3.2.4 TRENDS
3.3 MARKET SHARE ANALYSIS
4 ANGIOPLASTY PROCEDURES
4.1 INTRODUCTION
4.2 PLAIN OLD BALLOON ANGIOPLASTY (POBA)
4.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
4.4 PERCUTANEOUS TRANSLUMINAL (PERIPHERAL) ANGIOPLASTY (PTA)
5 ANGIOPLASTY BALLOONS
5.1 INTRODUCTION
5.2 BY BALLOON TYPE
5.2.1 OLD/NORMAL BALLOONS MARKET
5.2.2 CUTTING BALLOONS MARKET
5.2.3 SCORING BALLOONS MARKET
5.2.4 DRUG ELUTING BALLOONS MARKET
5.3 BY BALLOON PLATFORM
5.3.1 OVER-THE-WIRE BALLOON CATHETERS
5.3.2 RAPID EXCHANGE BALLOON CATHETERS
5.3.3 FIXED WIRE BALLOON CATHETERS
5.4 BY BALLOON MATERIAL
5.4.1 NON-COMPLIANT BALLOONS
5.4.2 SEMI-COMPLIANT BALLOONS
5.4.3 LOW-COMPLIANT BALLOONS
6 ANGIOPLASTY STENTS
6.1 INTRODUCTION
6.2 STENTS BY TYPE
6.2.1 BARE METAL STENTS
6.2.2 DRUG-ELUTING STENTS
6.2.3 BIOABSORBABLE STENTS
6.3 STENTS BY DELIVERY PLATFORM
6.3.1 SELF-EXPANDING STENTS
6.3.2 BALLOON-EXPANDABLE STENTS
7 CATHETERS
7.1 INTRODUCTION
7.2 ANGIOGRAPHY CATHETERS MARKET
7.3 INTRAVASCULAR ULTRASOUND (IVUS) CATHETERS MARKET
7.4 GUIDING CATHETERS MARKET
7.5 OPTICAL COHERENCE TOMOGRAPHY CATHETERS
8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET
8.1 ENDOVASCULAR ANEURYSM REPAIR MARKET
8.2 ABDOMINAL AORTIC ANEURYSM (AAA)
8.3 THORACIC AORTIC ANEURYSM (TAA)
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET
9.1 INFERIOR VENA CAVA FILTERS MARKET
9.2 PERMANENT IVC FILTERS
9.3 RETRIEVABLE IVC FILTERS
10 PLAQUE MODIFICATION DEVICES MARKET
10.1 INTRODUCTION
10.2 THROMBECTOMY DEVICES MARKET
10.3 ATHERECTOMY DEVICES MARKET
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET
11.1 INTRODUCTION
11.2 EMBOLIC PROTECTION DEVICES MARKET
11.3 CHRONIC TOTAL OCCLUSION DEVICES MARKET
12 ACCESSORY DEVICES
12.1 INTRODUCTION
12.2 VASCULAR CLOSURE DEVICES MARKET
12.3 INTRODUCER SHEATHS MARKET
12.4 GUIDE WIRES MARKET
12.5 BALLOON INFLATION DEVICES MARKET
13 GEOGRAPHIC ANALYSIS
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.3 EUROPE
13.4 ASIA
13.5 REST OF THE WORLD (ROW)
14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 KEY GROWTH STRATEGIES
14.3 MERGERS & ACQUISITIONS
14.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
14.5 NEW PRODUCTS LAUNCH
14.6 APPROVALS
14.7 EXPANSIONS
14.8 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 ABBOTT LABORATORIES
15.1.1 OVERVIEW
15.1.2 FINANCIALS
15.1.3 PRODUCTS & SERVICES
15.1.4 STRATEGY
15.1.5 DEVELOPMENTS
15.2 ACCESSCLOSURE INC.
15.2.1 OVERVIEW
15.2.2 FINANCIALS
15.2.3 PRODUCTS & SERVICES
15.2.4 STRATEGY
15.2.5 DEVELOPMENTS
15.3 ALN IMPLANTS CHIRURGICAUX
15.3.1 OVERVIEW
15.3.2 FINANCIALS
15.3.3 PRODUCTS & SERVICES
15.3.4 STRATEGY
15.4 ANGIOSCORE INC.
15.4.1 OVERVIEW
15.4.2 FINANCIALS
15.4.3 PRODUCTS & SERVICES
15.4.4 STRATEGY
15.4.5 DEVELOPMENTS
15.5 APTUS ENDOSYSTEMS INC.
15.5.1 OVERVIEW
15.5.2 FINANCIALS
15.5.3 PRODUCTS & SERVICES
15.5.4 STRATEGY
15.5.5 DEVELOPMENTS
15.6 ASAHI INTECC CO. LTD
15.6.1 OVERVIEW
15.6.2 FINANCIALS
15.6.3 PRODUCTS & SERVICES
15.6.4 STRATEGY
15.6.5 DEVELOPMENTS
15.7 BAYER AG
15.7.1 OVERVIEW
15.7.2 FINANCIALS
15.7.3 PRODUCTS & SERVICES
15.7.4 STRATEGY
15.7.5 DEVELOPMENTS
15.8 BIOSENSORS INTERNATIONAL GROUP LTD
15.8.1 OVERVIEW
15.8.2 FINANCIALS
15.8.3 PRODUCTS & SERVICES
15.8.4 STRATEGY
15.8.5 DEVELOPMENTS
15.9 BOLTON MEDICAL INC.
15.9.1 OVERVIEW
15.9.2 FINANCIALS
15.9.3 PRODUCTS & SERVICES
15.9.4 STRATEGY
15.9.5 DEVELOPMENTS
15.10 BOSTON SCIENTIFIC
15.10.1 OVERVIEW
15.10.2 FINANCIALS
15.10.3 PRODUCTS & SERVICES
15.10.4 STRATEGY
15.10.5 DEVELOPMENTS
15.11 B. BRAUN MELSUNGEN AG
15.11.1 OVERVIEW
15.11.2 FINANCIALS
15.11.3 PRODUCTS & SERVICES
15.11.4 STRATEGY
15.11.5 DEVELOPMENTS
15.12 CARDIODEX LTD
15.12.1 OVERVIEW
15.12.2 FINANCIALS
15.12.3 PRODUCTS & SERVICES
15.12.4 STRATEGY
15.13 COOK GROUP INC.
15.13.1 OVERVIEW
15.13.2 FINANCIALS
15.13.3 PRODUCTS & SERVICES
15.13.4 STRATEGY
15.13.5 DEVELOPMENTS
15.14 CORDIS CORPORATION
15.14.1 OVERVIEW
15.14.2 FINANCIALS
15.14.3 PRODUCTS & SERVICES
15.14.4 STRATEGY
15.14.5 DEVELOPMENTS
15.15 COVIDIEN PLC
15.15.1 OVERVIEW
15.15.2 FINANCIALS
15.15.3 PRODUCTS & SERVICES
15.15.4 STRATEGY
15.15.5 DEVELOPMENTS
15.16 C.R. BARD INC.
15.16.1 OVERVIEW
15.16.2 FINANCIALS
15.16.3 PRODUCTS & SERVICES
15.16.4 STRATEGY
15.16.5 DEVELOPMENTS
15.17 EDWARDS LIFESCIENCES CORPORATION
15.17.1 OVERVIEW
15.17.2 FINANCIALS
15.17.3 PRODUCTS & SERVICES
15.17.4 STRATEGY
15.17.5 DEVELOPMENTS
15.18 EMBOLINE INC.
15.18.1 OVERVIEW
15.18.2 FINANCIALS
15.18.3 PRODUCTS & SERVICES
15.18.4 STRATEGY
15.18.5 DEVELOPMENTS
15.19 ENDOLOGIX INC.
15.19.1 OVERVIEW
15.19.2 FINANCIALS
15.19.3 PRODUCTS & SERVICES
15.19.4 STRATEGY
15.19.5 DEVELOPMENTS
15.20 INSITU TECHNOLOGIES INC.
15.20.1 OVERVIEW
15.20.2 FINANCIALS
15.20.3 PRODUCTS & SERVICES
15.20.4 STRATEGY
15.21 JOTEC GMBH
15.21.1 OVERVIEW
15.21.2 FINANCIALS
15.21.3 PRODUCTS & SERVICES
15.21.4 STRATEGY
15.21.5 DEVELOPMENTS
15.22 LOMBARD MEDICAL TECHNOLOGIES PLC
15.22.1 OVERVIEW
15.22.2 FINANCIALS
15.22.3 PRODUCTS & SERVICES
15.22.4 STRATEGY
15.22.5 DEVELOPMENTS
15.23 MAQUET GMBH & CO. KG
15.23.1 OVERVIEW
15.23.2 FINANCIALS
15.23.3 PRODUCTS & SERVICES
15.23.4 STRATEGY
15.23.5 DEVELOPMENTS
15.24 MEDTRONIC INC.
15.24.1 OVERVIEW
15.24.2 FINANCIALS
15.24.3 PRODUCTS & SERVICES
15.24.4 STRATEGY
15.24.5 DEVELOPMENTS
15.25 MERIT MEDICAL SYSTEMS INC.
15.25.1 OVERVIEW
15.25.2 FINANCIALS
15.25.3 PRODUCTS & SERVICES
15.25.4 STRATEGY
15.25.5 DEVELOPMENTS
15.26 NEOMEND INC.
15.26.1 OVERVIEW
15.26.2 FINANCIALS
15.26.3 PRODUCTS & SERVICES
15.26.4 STRATEGY
15.26.5 DEVELOPMENTS
15.27 ORBUSNEICH
15.27.1 OVERVIEW
15.27.2 FINANCIALS
15.27.3 PRODUCTS & SERVICES
15.27.4 STRATEGY
15.27.5 DEVELOPMENTS
15.28 REX MEDICAL L.P.
15.28.1 OVERVIEW
15.28.2 FINANCIALS
15.28.3 PRODUCTS & SERVICES
15.28.4 STRATEGY
15.28.5 DEVELOPMENTS
15.29 ST. JUDE MEDICAL INC.
15.29.1 OVERVIEW
15.29.2 FINANCIALS
15.29.3 PRODUCTS & SERVICES
15.29.4 STRATEGY
15.29.5 DEVELOPMENTS
15.30 TELEFLEX INC.
15.30.1 OVERVIEW
15.30.2 FINANCIALS
15.30.3 PRODUCTS & SERVICES
15.30.4 STRATEGY
15.30.5 DEVELOPMENTS
15.31 TERUMO CORPORATION
15.31.1 OVERVIEW
15.31.2 FINANCIALS
15.31.3 PRODUCTS & SERVICES
15.31.4 STRATEGY
15.31.5 DEVELOPMENTS
15.32 THE SPECTRANETICS CORPORATION
15.32.1 OVERVIEW
15.32.2 FINANCIALS
15.32.3 PRODUCTS & SERVICES
15.32.4 STRATEGY
15.32.5 DEVELOPMENTS
15.33 VASCULAR SOLUTIONS INC.
15.33.1 OVERVIEW
15.33.2 FINANCIALS
15.33.3 PRODUCTS & SERVICES
15.33.4 STRATEGY
15.33.5 DEVELOPMENTS
15.34 VOLCANO CORPORATION
15.34.1 OVERVIEW
15.34.2 FINANCIALS
15.34.3 PRODUCTS & SERVICES
15.34.4 STRATEGY
15.34.5 DEVELOPMENTS
15.35 W. L. GORE & ASSOCIATES INC.
15.35.1 OVERVIEW
15.35.2 FINANCIALS
15.35.3 PRODUCTS & SERVICES
15.35.4 STRATEGY
15.35.5 DEVELOPMENTS
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Increasing Demand for Minimally Invasive Treatment
3.2.1.2 Increasing Incidence of Coronary Artery Disease
3.2.1.3 Increasing Prevalence of Peripheral Vascular Disease
3.2.1.4 Rapid Advancements in New Technologies
3.2.2 RESTRAINTS
3.2.2.1 Reimbursement Issues
3.2.2.2 Declining Average Selling Prices
3.2.2.3 Barrier to Entry
3.2.3 OPPORTUNITIES AND THREATS
3.2.4 TRENDS
3.3 MARKET SHARE ANALYSIS
4 ANGIOPLASTY PROCEDURES
4.1 INTRODUCTION
4.2 PLAIN OLD BALLOON ANGIOPLASTY (POBA)
4.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
4.4 PERCUTANEOUS TRANSLUMINAL (PERIPHERAL) ANGIOPLASTY (PTA)
5 ANGIOPLASTY BALLOONS
5.1 INTRODUCTION
5.2 BY BALLOON TYPE
5.2.1 OLD/NORMAL BALLOONS MARKET
5.2.2 CUTTING BALLOONS MARKET
5.2.3 SCORING BALLOONS MARKET
5.2.4 DRUG ELUTING BALLOONS MARKET
5.3 BY BALLOON PLATFORM
5.3.1 OVER-THE-WIRE BALLOON CATHETERS
5.3.2 RAPID EXCHANGE BALLOON CATHETERS
5.3.3 FIXED WIRE BALLOON CATHETERS
5.4 BY BALLOON MATERIAL
5.4.1 NON-COMPLIANT BALLOONS
5.4.2 SEMI-COMPLIANT BALLOONS
5.4.3 LOW-COMPLIANT BALLOONS
6 ANGIOPLASTY STENTS
6.1 INTRODUCTION
6.2 STENTS BY TYPE
6.2.1 BARE METAL STENTS
6.2.2 DRUG-ELUTING STENTS
6.2.3 BIOABSORBABLE STENTS
6.3 STENTS BY DELIVERY PLATFORM
6.3.1 SELF-EXPANDING STENTS
6.3.2 BALLOON-EXPANDABLE STENTS
7 CATHETERS
7.1 INTRODUCTION
7.2 ANGIOGRAPHY CATHETERS MARKET
7.3 INTRAVASCULAR ULTRASOUND (IVUS) CATHETERS MARKET
7.4 GUIDING CATHETERS MARKET
7.5 OPTICAL COHERENCE TOMOGRAPHY CATHETERS
8 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET
8.1 ENDOVASCULAR ANEURYSM REPAIR MARKET
8.2 ABDOMINAL AORTIC ANEURYSM (AAA)
8.3 THORACIC AORTIC ANEURYSM (TAA)
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET
9.1 INFERIOR VENA CAVA FILTERS MARKET
9.2 PERMANENT IVC FILTERS
9.3 RETRIEVABLE IVC FILTERS
10 PLAQUE MODIFICATION DEVICES MARKET
10.1 INTRODUCTION
10.2 THROMBECTOMY DEVICES MARKET
10.3 ATHERECTOMY DEVICES MARKET
11 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET
11.1 INTRODUCTION
11.2 EMBOLIC PROTECTION DEVICES MARKET
11.3 CHRONIC TOTAL OCCLUSION DEVICES MARKET
12 ACCESSORY DEVICES
12.1 INTRODUCTION
12.2 VASCULAR CLOSURE DEVICES MARKET
12.3 INTRODUCER SHEATHS MARKET
12.4 GUIDE WIRES MARKET
12.5 BALLOON INFLATION DEVICES MARKET
13 GEOGRAPHIC ANALYSIS
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.3 EUROPE
13.4 ASIA
13.5 REST OF THE WORLD (ROW)
14 COMPETITIVE LANDSCAPE
14.1 INTRODUCTION
14.2 KEY GROWTH STRATEGIES
14.3 MERGERS & ACQUISITIONS
14.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES
14.5 NEW PRODUCTS LAUNCH
14.6 APPROVALS
14.7 EXPANSIONS
14.8 OTHER DEVELOPMENTS
15 COMPANY PROFILES
15.1 ABBOTT LABORATORIES
15.1.1 OVERVIEW
15.1.2 FINANCIALS
15.1.3 PRODUCTS & SERVICES
15.1.4 STRATEGY
15.1.5 DEVELOPMENTS
15.2 ACCESSCLOSURE INC.
15.2.1 OVERVIEW
15.2.2 FINANCIALS
15.2.3 PRODUCTS & SERVICES
15.2.4 STRATEGY
15.2.5 DEVELOPMENTS
15.3 ALN IMPLANTS CHIRURGICAUX
15.3.1 OVERVIEW
15.3.2 FINANCIALS
15.3.3 PRODUCTS & SERVICES
15.3.4 STRATEGY
15.4 ANGIOSCORE INC.
15.4.1 OVERVIEW
15.4.2 FINANCIALS
15.4.3 PRODUCTS & SERVICES
15.4.4 STRATEGY
15.4.5 DEVELOPMENTS
15.5 APTUS ENDOSYSTEMS INC.
15.5.1 OVERVIEW
15.5.2 FINANCIALS
15.5.3 PRODUCTS & SERVICES
15.5.4 STRATEGY
15.5.5 DEVELOPMENTS
15.6 ASAHI INTECC CO. LTD
15.6.1 OVERVIEW
15.6.2 FINANCIALS
15.6.3 PRODUCTS & SERVICES
15.6.4 STRATEGY
15.6.5 DEVELOPMENTS
15.7 BAYER AG
15.7.1 OVERVIEW
15.7.2 FINANCIALS
15.7.3 PRODUCTS & SERVICES
15.7.4 STRATEGY
15.7.5 DEVELOPMENTS
15.8 BIOSENSORS INTERNATIONAL GROUP LTD
15.8.1 OVERVIEW
15.8.2 FINANCIALS
15.8.3 PRODUCTS & SERVICES
15.8.4 STRATEGY
15.8.5 DEVELOPMENTS
15.9 BOLTON MEDICAL INC.
15.9.1 OVERVIEW
15.9.2 FINANCIALS
15.9.3 PRODUCTS & SERVICES
15.9.4 STRATEGY
15.9.5 DEVELOPMENTS
15.10 BOSTON SCIENTIFIC
15.10.1 OVERVIEW
15.10.2 FINANCIALS
15.10.3 PRODUCTS & SERVICES
15.10.4 STRATEGY
15.10.5 DEVELOPMENTS
15.11 B. BRAUN MELSUNGEN AG
15.11.1 OVERVIEW
15.11.2 FINANCIALS
15.11.3 PRODUCTS & SERVICES
15.11.4 STRATEGY
15.11.5 DEVELOPMENTS
15.12 CARDIODEX LTD
15.12.1 OVERVIEW
15.12.2 FINANCIALS
15.12.3 PRODUCTS & SERVICES
15.12.4 STRATEGY
15.13 COOK GROUP INC.
15.13.1 OVERVIEW
15.13.2 FINANCIALS
15.13.3 PRODUCTS & SERVICES
15.13.4 STRATEGY
15.13.5 DEVELOPMENTS
15.14 CORDIS CORPORATION
15.14.1 OVERVIEW
15.14.2 FINANCIALS
15.14.3 PRODUCTS & SERVICES
15.14.4 STRATEGY
15.14.5 DEVELOPMENTS
15.15 COVIDIEN PLC
15.15.1 OVERVIEW
15.15.2 FINANCIALS
15.15.3 PRODUCTS & SERVICES
15.15.4 STRATEGY
15.15.5 DEVELOPMENTS
15.16 C.R. BARD INC.
15.16.1 OVERVIEW
15.16.2 FINANCIALS
15.16.3 PRODUCTS & SERVICES
15.16.4 STRATEGY
15.16.5 DEVELOPMENTS
15.17 EDWARDS LIFESCIENCES CORPORATION
15.17.1 OVERVIEW
15.17.2 FINANCIALS
15.17.3 PRODUCTS & SERVICES
15.17.4 STRATEGY
15.17.5 DEVELOPMENTS
15.18 EMBOLINE INC.
15.18.1 OVERVIEW
15.18.2 FINANCIALS
15.18.3 PRODUCTS & SERVICES
15.18.4 STRATEGY
15.18.5 DEVELOPMENTS
15.19 ENDOLOGIX INC.
15.19.1 OVERVIEW
15.19.2 FINANCIALS
15.19.3 PRODUCTS & SERVICES
15.19.4 STRATEGY
15.19.5 DEVELOPMENTS
15.20 INSITU TECHNOLOGIES INC.
15.20.1 OVERVIEW
15.20.2 FINANCIALS
15.20.3 PRODUCTS & SERVICES
15.20.4 STRATEGY
15.21 JOTEC GMBH
15.21.1 OVERVIEW
15.21.2 FINANCIALS
15.21.3 PRODUCTS & SERVICES
15.21.4 STRATEGY
15.21.5 DEVELOPMENTS
15.22 LOMBARD MEDICAL TECHNOLOGIES PLC
15.22.1 OVERVIEW
15.22.2 FINANCIALS
15.22.3 PRODUCTS & SERVICES
15.22.4 STRATEGY
15.22.5 DEVELOPMENTS
15.23 MAQUET GMBH & CO. KG
15.23.1 OVERVIEW
15.23.2 FINANCIALS
15.23.3 PRODUCTS & SERVICES
15.23.4 STRATEGY
15.23.5 DEVELOPMENTS
15.24 MEDTRONIC INC.
15.24.1 OVERVIEW
15.24.2 FINANCIALS
15.24.3 PRODUCTS & SERVICES
15.24.4 STRATEGY
15.24.5 DEVELOPMENTS
15.25 MERIT MEDICAL SYSTEMS INC.
15.25.1 OVERVIEW
15.25.2 FINANCIALS
15.25.3 PRODUCTS & SERVICES
15.25.4 STRATEGY
15.25.5 DEVELOPMENTS
15.26 NEOMEND INC.
15.26.1 OVERVIEW
15.26.2 FINANCIALS
15.26.3 PRODUCTS & SERVICES
15.26.4 STRATEGY
15.26.5 DEVELOPMENTS
15.27 ORBUSNEICH
15.27.1 OVERVIEW
15.27.2 FINANCIALS
15.27.3 PRODUCTS & SERVICES
15.27.4 STRATEGY
15.27.5 DEVELOPMENTS
15.28 REX MEDICAL L.P.
15.28.1 OVERVIEW
15.28.2 FINANCIALS
15.28.3 PRODUCTS & SERVICES
15.28.4 STRATEGY
15.28.5 DEVELOPMENTS
15.29 ST. JUDE MEDICAL INC.
15.29.1 OVERVIEW
15.29.2 FINANCIALS
15.29.3 PRODUCTS & SERVICES
15.29.4 STRATEGY
15.29.5 DEVELOPMENTS
15.30 TELEFLEX INC.
15.30.1 OVERVIEW
15.30.2 FINANCIALS
15.30.3 PRODUCTS & SERVICES
15.30.4 STRATEGY
15.30.5 DEVELOPMENTS
15.31 TERUMO CORPORATION
15.31.1 OVERVIEW
15.31.2 FINANCIALS
15.31.3 PRODUCTS & SERVICES
15.31.4 STRATEGY
15.31.5 DEVELOPMENTS
15.32 THE SPECTRANETICS CORPORATION
15.32.1 OVERVIEW
15.32.2 FINANCIALS
15.32.3 PRODUCTS & SERVICES
15.32.4 STRATEGY
15.32.5 DEVELOPMENTS
15.33 VASCULAR SOLUTIONS INC.
15.33.1 OVERVIEW
15.33.2 FINANCIALS
15.33.3 PRODUCTS & SERVICES
15.33.4 STRATEGY
15.33.5 DEVELOPMENTS
15.34 VOLCANO CORPORATION
15.34.1 OVERVIEW
15.34.2 FINANCIALS
15.34.3 PRODUCTS & SERVICES
15.34.4 STRATEGY
15.34.5 DEVELOPMENTS
15.35 W. L. GORE & ASSOCIATES INC.
15.35.1 OVERVIEW
15.35.2 FINANCIALS
15.35.3 PRODUCTS & SERVICES
15.35.4 STRATEGY
15.35.5 DEVELOPMENTS
LIST OF TABLES
TABLE 1 GLOBAL STENTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 2 GLOBAL ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 3 ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 4 GLOBAL CORONARY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 5 CORONARY ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 6 GLOBAL PERIPHERAL PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 7 PERIPHERAL ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 8 GLOBAL PTA PROCEDURES, BY BALLOON TYPE, 2009 – 2016
TABLE 9 PTA PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 10 GLOBAL PTCA PROCEDURES, BY BALLOON TYPE, 2009 – 2016
TABLE 11 PTCA PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 12 GLOBAL PTA MARKET REVENUE, BY BALLOON TYPE, 2009 – 2016 ($MILLION)
TABLE 13 PTA MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 14 GLOBAL PTCA MARKET REVENUE, BY BALLOON TYPE, 2009 – 2016 ($MILLION)
TABLE 15 PTCA MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 16 GLOBAL PLAIN OLD/NORMAL BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 17 GLOBAL PLAIN OLD/NORMAL BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 18 PLAIN OLD/NORMAL BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 19 PLAIN OLD/NORMAL BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 20 GLOBAL CUTTING BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 21 GLOBAL CUTTING BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 22 CUTTING BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 23 CUTTING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 24 GLOBAL SCORING BALLOONS PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 25 GLOBAL SCORING BALLOONS MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 26 SCORING BALLOONS PROCEDURES, BY GEOGRAPHY, 2012 – 2016
TABLE 27 SCORING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2012 – 2016 ($MILLION)
TABLE 28 GLOBAL DRUG ELUTING BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 29 GLOBAL DRUG ELUTING BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 30 DRUG ELUTING BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 31 DRUG ELUTING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 32 GLOBAL STENT MARKET VOLUME, BY SEGMENTS, 2009 – 2016
TABLE 33 STENTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 34 GLOBAL CORONARY STENT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 35 CORONARY STENT PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 36 GLOBAL PERIPHERAL STENT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 37 PERIPHERAL STENT PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 38 GLOBAL STENTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 39 STENTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 40 GLOBAL STENTS IN CORONARY PROCEDURES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 41 STENTS IN CORONARY PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 42 GLOBAL STENTS IN PERIPHERAL PROCEDURES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 43 STENTS IN PERIPHERAL PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 44 GLOBAL SELF-EXPANDING STENTS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 45 SELF-EXPANDING STENTS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 46 SELF-EXPANDING STENTS IN CORONARY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 47 SELF-EXPANDING STENTS IN PERIPHERAL PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 48 GLOBAL BALLOON-EXPANDABLE STENTS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 49 BALLOON-EXPANDABLE STENTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 50 BALLOON-EXPANDABLE STENTS MARKET VOLUME IN CORONARY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 51 BALLOON-EXPANDABLE STENTS MARKET VOLUME IN PERIPHERAL PROCEDURES, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 52 ANGIOGRAPHY CATHETERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 53 ANGIOGRAPHY CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 54 IVUS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 55 IVUS CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 56 GUIDING CATHETERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 57 GUIDING CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 58 GLOBAL EVAR STENTS GRAFT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 59 GLOBAL EVAR STENT GRAFTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 60 EVAR STENT GRAFTS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 61 EVAR STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 62 ABDOMINAL AORTIC ANEURYSM WITH EVAR PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 63 ABDOMINAL AORTIC STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 64 THORACIC AORTIC ANEURYSM WITH EVAR PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 65 THORACIC AORTIC STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 66 INFERIOR VENA CAVA FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 67 GLOBAL IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 68 GLOBAL IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 69 IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 70 PERMANENT IVC FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 71 PERMANENT IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 72 RETRIEVABLE IVC FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 73 RETRIEVABLE IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 74 GLOBAL PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 75 PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 76 PLAQUE MODIFICATION THROMBECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 77 PLAQUE MODIFICATION ATHERECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 78 GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 79 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 80 EMBOLIC PROTECTION HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 81 CTO HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 82 VASCULAR CLOSURE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 83 VASCULAR CLOSURE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 84 INTRODUCER SHEATHS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 85 INTRODUCER SHEATHS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 86 GUIDE WIRES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 87 GUIDE WIRES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 88 BALLOON INFLATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 89 BALLOON INFLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 90 NORTH AMERICA: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 91 NORTH AMERICA: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 92 NORTH AMERICA: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 93 NORTH AMERICA: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 94 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLIONS)
TABLE 95 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 96 NORTH AMERICA: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 97 NORTH AMERICA: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 98 NORTH AMERICA: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 99 NORTH AMERICA: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 100 NORTH AMERICA: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 101 NORTH AMERICA: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 102 NORTH AMERICA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 103 NORTH AMERICA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 104 NORTH AMERICA: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 105 EUROPE: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 106 EUROPE: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 107 EUROPE: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2012 – 2016 (NO. OF UNITS)
TABLE 108 EUROPE: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 109 EUROPE: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 110 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 111 EUROPE: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 112 EUROPE: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 113 EUROPE: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 114 EUROPE: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 115 EUROPE: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 116 EUROPE: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 117 EUROPE: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 118 EUROPE: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 119 EUROPE: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE, (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 120 ASIA: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 121 ASIA: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 122 ASIA: IVC FILTERS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 123 ASIA: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 124 ASIA: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 125 ASIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 126 ASIA: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 127 ASIA: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 128 ASIA: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 129 ASIA: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 130 ASIA: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 131 ASIA: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 132 ASIA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 133 ASIA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 134 ASIA: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 135 ROW: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 136 ROW: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 137 ROW: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016
TABLE 138 ROW: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 139 ROW: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 140 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 141 ROW: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 142 ROW: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 143 ROW: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 144 ROW: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 145 ROW: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 146 ROW: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 147 ROW: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 148 ROW: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 149 ROW: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE, (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 150 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 151 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 152 NEW PRODUCTS LAUNCH, 2009 – 2012
TABLE 153 APPROVALS, 2009 – 2012
TABLE 154 EXPANSIONS, 2009 –2012
TABLE 155 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 156 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 157 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 158 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 159 ASAHI INTECC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 160 ASAHI INTECC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 161 ASAHI INTECC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 162 BAYER AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 163 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 164 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 165 BIOSENSORS INTERNATIONAL GROUP LTD: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 166 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 167 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 168 BOSTON SCIENTIFIC : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 169 BOSTON SCIENTIFIC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 170 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 171 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 172 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 173 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 174 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 175 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 176 COVIDIEN PLC : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 177 C.R. BARD INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 178 C.R. BARD INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 179 C.R. BARD INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 180 EDWARDS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 181 EDWARDS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 182 EDWARDS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 183 ENDOLOGIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 184 ENDOLOGIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 185 LOMBARD: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 186 LOMBARD: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 187 GETINGE AB : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 188 GETINGE AB : TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 189 GETINGE AB: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2011 ($MILLION)
TABLE 190 MEDTRONIC INC: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 191 MEDTRONIC INC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 192 MEDTRONIC INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 193 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 194 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 195 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 196 ST. JUDE MEDICAL INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 197 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 198 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 199 TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 200 TELEFLEX: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 201 TELEFLEX: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 202 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 203 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 204 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 205 THE SPECTRANETICS CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 206 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 207 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 208 VASCULAR SOLUTIONS: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 209 VASCULAR SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 210 VASCULAR SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 211 VOLCANO CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 212 VOLCANO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 213 VOLCANO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 1 GLOBAL STENTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 2 GLOBAL ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 3 ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 4 GLOBAL CORONARY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 5 CORONARY ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 6 GLOBAL PERIPHERAL PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 7 PERIPHERAL ANGIOPLASTY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 8 GLOBAL PTA PROCEDURES, BY BALLOON TYPE, 2009 – 2016
TABLE 9 PTA PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 10 GLOBAL PTCA PROCEDURES, BY BALLOON TYPE, 2009 – 2016
TABLE 11 PTCA PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 12 GLOBAL PTA MARKET REVENUE, BY BALLOON TYPE, 2009 – 2016 ($MILLION)
TABLE 13 PTA MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 14 GLOBAL PTCA MARKET REVENUE, BY BALLOON TYPE, 2009 – 2016 ($MILLION)
TABLE 15 PTCA MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 16 GLOBAL PLAIN OLD/NORMAL BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 17 GLOBAL PLAIN OLD/NORMAL BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 18 PLAIN OLD/NORMAL BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 19 PLAIN OLD/NORMAL BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 20 GLOBAL CUTTING BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 21 GLOBAL CUTTING BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 22 CUTTING BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 23 CUTTING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 24 GLOBAL SCORING BALLOONS PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 25 GLOBAL SCORING BALLOONS MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 26 SCORING BALLOONS PROCEDURES, BY GEOGRAPHY, 2012 – 2016
TABLE 27 SCORING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2012 – 2016 ($MILLION)
TABLE 28 GLOBAL DRUG ELUTING BALLOONS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 29 GLOBAL DRUG ELUTING BALLOONS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 30 DRUG ELUTING BALLOONS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 31 DRUG ELUTING BALLOONS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 32 GLOBAL STENT MARKET VOLUME, BY SEGMENTS, 2009 – 2016
TABLE 33 STENTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 34 GLOBAL CORONARY STENT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 35 CORONARY STENT PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 36 GLOBAL PERIPHERAL STENT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 37 PERIPHERAL STENT PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 38 GLOBAL STENTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 39 STENTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 40 GLOBAL STENTS IN CORONARY PROCEDURES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 41 STENTS IN CORONARY PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 42 GLOBAL STENTS IN PERIPHERAL PROCEDURES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 43 STENTS IN PERIPHERAL PROCEDURES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 44 GLOBAL SELF-EXPANDING STENTS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 45 SELF-EXPANDING STENTS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 46 SELF-EXPANDING STENTS IN CORONARY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 47 SELF-EXPANDING STENTS IN PERIPHERAL PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 48 GLOBAL BALLOON-EXPANDABLE STENTS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 49 BALLOON-EXPANDABLE STENTS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 50 BALLOON-EXPANDABLE STENTS MARKET VOLUME IN CORONARY PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 51 BALLOON-EXPANDABLE STENTS MARKET VOLUME IN PERIPHERAL PROCEDURES, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 52 ANGIOGRAPHY CATHETERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 53 ANGIOGRAPHY CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 54 IVUS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 55 IVUS CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 56 GUIDING CATHETERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 57 GUIDING CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 58 GLOBAL EVAR STENTS GRAFT PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 59 GLOBAL EVAR STENT GRAFTS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 60 EVAR STENT GRAFTS PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 61 EVAR STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 62 ABDOMINAL AORTIC ANEURYSM WITH EVAR PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 63 ABDOMINAL AORTIC STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 64 THORACIC AORTIC ANEURYSM WITH EVAR PROCEDURES, BY GEOGRAPHY, 2009 – 2016
TABLE 65 THORACIC AORTIC STENT GRAFTS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 66 INFERIOR VENA CAVA FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 67 GLOBAL IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 68 GLOBAL IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 69 IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 70 PERMANENT IVC FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 71 PERMANENT IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 72 RETRIEVABLE IVC FILTERS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (NO. OF UNITS)
TABLE 73 RETRIEVABLE IVC FILTERS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 74 GLOBAL PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 75 PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 76 PLAQUE MODIFICATION THROMBECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 77 PLAQUE MODIFICATION ATHERECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 78 GLOBAL HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 79 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 80 EMBOLIC PROTECTION HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 81 CTO HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 82 VASCULAR CLOSURE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 83 VASCULAR CLOSURE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 84 INTRODUCER SHEATHS MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 85 INTRODUCER SHEATHS MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 86 GUIDE WIRES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 87 GUIDE WIRES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 88 BALLOON INFLATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016 (THOUSAND UNITS)
TABLE 89 BALLOON INFLATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 – 2016 ($MILLION)
TABLE 90 NORTH AMERICA: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 91 NORTH AMERICA: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 92 NORTH AMERICA: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016 (NO. OF UNITS)
TABLE 93 NORTH AMERICA: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 94 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLIONS)
TABLE 95 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 96 NORTH AMERICA: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 97 NORTH AMERICA: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 98 NORTH AMERICA: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 99 NORTH AMERICA: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 100 NORTH AMERICA: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 101 NORTH AMERICA: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 102 NORTH AMERICA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 103 NORTH AMERICA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 104 NORTH AMERICA: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 105 EUROPE: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 106 EUROPE: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 107 EUROPE: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2012 – 2016 (NO. OF UNITS)
TABLE 108 EUROPE: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 109 EUROPE: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 110 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 111 EUROPE: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 112 EUROPE: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 113 EUROPE: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 114 EUROPE: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 115 EUROPE: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 116 EUROPE: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 117 EUROPE: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 118 EUROPE: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 119 EUROPE: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE, (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 120 ASIA: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 121 ASIA: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 122 ASIA: IVC FILTERS PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 123 ASIA: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 124 ASIA: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 125 ASIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 126 ASIA: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 127 ASIA: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 128 ASIA: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 129 ASIA: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 130 ASIA: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 131 ASIA: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 132 ASIA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 133 ASIA: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 134 ASIA: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 135 ROW: EVAR PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 136 ROW: ENDOVASCULAR ANEURYSM REPAIR MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 137 ROW: IVC FILTERS MARKET VOLUME, BY SEGMENTS, 2009 – 2016
TABLE 138 ROW: IVC FILTERS MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 139 ROW: PLAQUE MODIFICATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 140 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 141 ROW: CUTTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 142 ROW: CUTTING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 143 ROW: SCORING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2012 – 2016
TABLE 144 ROW: SCORING BALLOONS ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2012 – 2016 ($MILLION)
TABLE 145 ROW: DRUG ELUTING BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 146 ROW: DRUG ELUTING BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 147 ROW: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY PROCEDURES, BY SEGMENTS, 2009 – 2016
TABLE 148 ROW: PLAIN OLD/NORMAL BALLOON ANGIOPLASTY MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 149 ROW: INTERVENTIONAL VASCULAR DEVICES MARKET REVENUE, (EXCLUDING BALLOON DEVICES), BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 150 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 151 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, JOINT VENTURES, 2009 – 2012
TABLE 152 NEW PRODUCTS LAUNCH, 2009 – 2012
TABLE 153 APPROVALS, 2009 – 2012
TABLE 154 EXPANSIONS, 2009 –2012
TABLE 155 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 156 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 157 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 158 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 159 ASAHI INTECC.: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 160 ASAHI INTECC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 161 ASAHI INTECC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 162 BAYER AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 163 BAYER AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 164 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 165 BIOSENSORS INTERNATIONAL GROUP LTD: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 166 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 167 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 168 BOSTON SCIENTIFIC : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 169 BOSTON SCIENTIFIC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 170 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 171 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 172 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 173 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 174 COVIDIEN PLC : TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 175 COVIDIEN PLC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 176 COVIDIEN PLC : TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 177 C.R. BARD INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 178 C.R. BARD INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 179 C.R. BARD INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 180 EDWARDS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 181 EDWARDS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 182 EDWARDS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 183 ENDOLOGIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 184 ENDOLOGIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 185 LOMBARD: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 186 LOMBARD: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 187 GETINGE AB : TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 188 GETINGE AB : TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 189 GETINGE AB: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2011 ($MILLION)
TABLE 190 MEDTRONIC INC: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 191 MEDTRONIC INC: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 192 MEDTRONIC INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 193 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 194 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 195 MERIT MEDICAL SYSTEMS INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 196 ST. JUDE MEDICAL INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 197 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 198 ST. JUDE MEDICAL INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 199 TELEFLEX: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 200 TELEFLEX: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 201 TELEFLEX: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 202 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)
TABLE 203 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 204 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 205 THE SPECTRANETICS CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 206 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 207 THE SPECTRANETICS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 208 VASCULAR SOLUTIONS: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 209 VASCULAR SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 210 VASCULAR SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 211 VOLCANO CORPORATION: TOTAL REVENUE AND R&D EXPENSE, 2008 – 2010 ($MILLION)
TABLE 212 VOLCANO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 213 VOLCANO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL ANGIOPLASTY PROCEDURES, BY SEGMENTS (2009-2016)
FIGURE 2 GEOGRAPHIC RANKING OF TOTAL STENTS MARKET
FIGURE 3 MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2010
FIGURE 6 ANGIOPLASTY PROCEDURES SEGMENTATION
FIGURE 7 ANGIOPLASTY BALLOONS SEGMENTATION
FIGURE 8 ANGIOPLASTY STENTS SEGMENTATION
FIGURE 9 CATHETERS MARKET SEGMENTATION
FIGURE 10 OPTICAL COHERENCE TOMOGRAPHY PROCESS
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) SEGMENTATION
FIGURE 12 INFERIOR VENA CAVA FILTERS SEGMENTATION
FIGURE 13 PLAQUE MODIFICATION DEVICES SEGMENTATION
FIGURE 14 HEMODYNAMIC FLOW ALTERATION DEVICES SEGMENTATION
FIGURE 15 ACCESSORY DEVICES SEGMENTATION
FIGURE 16 KEY GROWTH STRATEGIES, JANUARY 2009 - FEBRUARY 2012
FIGURE 1 GLOBAL ANGIOPLASTY PROCEDURES, BY SEGMENTS (2009-2016)
FIGURE 2 GEOGRAPHIC RANKING OF TOTAL STENTS MARKET
FIGURE 3 MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2010
FIGURE 6 ANGIOPLASTY PROCEDURES SEGMENTATION
FIGURE 7 ANGIOPLASTY BALLOONS SEGMENTATION
FIGURE 8 ANGIOPLASTY STENTS SEGMENTATION
FIGURE 9 CATHETERS MARKET SEGMENTATION
FIGURE 10 OPTICAL COHERENCE TOMOGRAPHY PROCESS
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) SEGMENTATION
FIGURE 12 INFERIOR VENA CAVA FILTERS SEGMENTATION
FIGURE 13 PLAQUE MODIFICATION DEVICES SEGMENTATION
FIGURE 14 HEMODYNAMIC FLOW ALTERATION DEVICES SEGMENTATION
FIGURE 15 ACCESSORY DEVICES SEGMENTATION
FIGURE 16 KEY GROWTH STRATEGIES, JANUARY 2009 - FEBRUARY 2012
